Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7242
Delayed Data
As of 4:00pm ET
 +0.0142 / +2.00%
Today’s Change
0.65
Today|||52-Week Range
1.04
+3.46%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.71
Today’s open0.72
Day’s range0.71 - 0.74
Volume815,875
Average volume (3 months)573,362
Market cap$127.5M
Dividend yield--
Data as of 4:00pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...+0.58+10.72%
LPCNLipocine Inc-0.02-0.28%
AVEOAveo Pharmaceuticals...-0.12-5.29%
CLCDCoLucid Pharmaceutic...-0.07-0.81%
Data as of 4:14pm ET, 05/27/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers